Arkolith/Insider Trading/ONCT/Form 4

Hale David F

DirectorOncternal Therapeutics, Inc. (ONCT) · full profile →Form 4 · filed Feb 27, 2024
Net Buying
Open-Market Buys
$9K
Open-Market Sells
$0
Net Open-Market Flow
$9K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 23, 2024Buy(P)714$9.04$6K714
Feb 23, 2024Buy(P)266$9.04$2K30K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-24-004016) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML